139 related articles for article (PubMed ID: 35868951)
1. Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
Kumazu Y; Hasegawa S; Hayashi T; Yamada T; Watanabe H; Hara K; Shimoda Y; Nakazono M; Nagasawa S; Rino Y; Masuda M; Ogata T; Oshima T; Yoshikawa T
Eur J Surg Oncol; 2023 Jan; 49(1):76-82. PubMed ID: 35868951
[TBL] [Abstract][Full Text] [Related]
2. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
[TBL] [Abstract][Full Text] [Related]
3. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
[TBL] [Abstract][Full Text] [Related]
4. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
Goto H; Tokunaga M; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
Gastric Cancer; 2013 Oct; 16(4):590-5. PubMed ID: 23179369
[TBL] [Abstract][Full Text] [Related]
5. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathologic feature-based nomogram for preoperative estimation of splenic hilar lymph node metastasis in advanced proximal gastric cancer without invasion of the greater curvature.
Cai Z; Lin H; Li Z; Zhou J; Chen W; Wu J; Zhang W; Wu H; Guo Z; Xu Y
Surgery; 2024 Jul; 176(1):100-107. PubMed ID: 38584073
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
[TBL] [Abstract][Full Text] [Related]
8. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
[TBL] [Abstract][Full Text] [Related]
9. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
Ding P; Gao Z; Zheng C; Chen J; Li K; Gao S
BMC Cancer; 2019 Sep; 19(1):905. PubMed ID: 31510966
[TBL] [Abstract][Full Text] [Related]
10. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
[TBL] [Abstract][Full Text] [Related]
11. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic value of splenectomy to dissect splenic hilar lymph nodes for type 4 gastric cancer involving the greater curvature, compared with other types.
Kano Y; Ohashi M; Ida S; Kumagai K; Makuuchi R; Sano T; Hiki N; Nunobe S
Gastric Cancer; 2020 Sep; 23(5):927-936. PubMed ID: 32307689
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
14. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].
Li SM; Li ZY; Ji X
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):288-91. PubMed ID: 23985258
[TBL] [Abstract][Full Text] [Related]
16. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
17. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
Lin JX; Wu D; Jiang YM; Chen JY; Lin GT; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Zheng CH; Huang CM
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):853-859. PubMed ID: 36058712
[No Abstract] [Full Text] [Related]
18. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature.
Yura M; Yoshikawa T; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
Ann Surg Oncol; 2019 Mar; 26(3):829-835. PubMed ID: 30569298
[TBL] [Abstract][Full Text] [Related]
20. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients.
Kosuga T; Ichikawa D; Okamoto K; Komatsu S; Shiozaki A; Fujiwara H; Otsuji E
Gastric Cancer; 2011 Jun; 14(2):172-7. PubMed ID: 21331530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
